Stem Cell Reviews and Reports
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.9 | Q2 | 73.3% | 1.217 | Q2 | 88.3% |
| 2024 | 4.2 | Q2 | 71.8% | 1.219 | Q2 | 88.7% |
| 2023 | 4.5 | Q2 | 72.8% | 1.190 | Q2 | 89.1% |
| 2022 | 4.8 | Q2 | 72.3% | 1.067 | Q2 | 87.7% |
| 2021 | 6.7 | Q2 | 82.4% | 1.078 | Q2 | 88.0% |
| 2020 | — | — | 1.247 | Q2 | 89.6% | |
| 2019 | — | — | 1.408 | Q2 | 91.8% | |
| 2018 | — | — | 1.436 | Q2 | 91.1% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2629-3277
ISSN
2629-3269
country
UScoverage
2009-2026